» Articles » PMID: 31189077

Transcriptomic Analysis Reveals That BMP4 Sensitizes Glioblastoma Tumor-initiating Cells to Mechanical Cues

Overview
Journal Matrix Biol
Publisher Elsevier
Date 2019 Jun 13
PMID 31189077
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The poor prognosis of glioblastoma (GBM) is associated with a highly invasive stem-like subpopulation of tumor-initiating cells (TICs), which drive recurrence and contribute to intra-tumoral heterogeneity through differentiation. These TICs are better able to escape extracellular matrix-imposed mechanical restrictions on invasion than their more differentiated progeny, and sensitization of TICs to extracellular matrix mechanics extends survival in preclinical models of GBM. However, little is known about the molecular basis of the relationship between TIC differentiation and mechanotransduction. Here we explore this relationship through a combination of transcriptomic analysis and studies with defined-stiffness matrices. We show that TIC differentiation induced by bone morphogenetic protein 4 (BMP4) suppresses expression of proteins relevant to extracellular matrix signaling and sensitizes TIC spreading to matrix stiffness. Moreover, our findings point towards a previously unappreciated connection between BMP4-induced differentiation, mechanotransduction, and metabolism. Notably, stiffness and differentiation modulate oxygen consumption, and inhibition of oxidative phosphorylation influences cell spreading in a stiffness- and differentiation-dependent manner. Our work integrates bioinformatic analysis with targeted molecular measurements and perturbations to yield new insight into how morphogen-induced differentiation influences how GBM TICs process mechanical inputs.

Citing Articles

Insights into the mechanisms, regulation, and therapeutic implications of extracellular matrix stiffness in cancer.

Zhang X, Al-Danakh A, Zhu X, Feng D, Yang L, Wu H Bioeng Transl Med. 2025; 10(1):e10698.

PMID: 39801760 PMC: 11711218. DOI: 10.1002/btm2.10698.


Delineating the glioblastoma stemness by genes involved in cytoskeletal rearrangements and metabolic alterations.

Kaluzinska-Kolat Z, Kolat D, Kosla K, Pluciennik E, Bednarek A World J Stem Cells. 2023; 15(5):302-322.

PMID: 37342224 PMC: 10277965. DOI: 10.4252/wjsc.v15.i5.302.


Glioma stem cells and neural stem cells respond differently to BMP4 signaling.

Han X, Cai C, Yu L, Wang M, Yang W, Hu D Cell Regen. 2022; 11(1):36.

PMID: 36316503 PMC: 9622962. DOI: 10.1186/s13619-022-00136-5.


Bioengineered Models to Study Microenvironmental Regulation of Glioblastoma Metabolism.

Chen J, Lee H, Schmitt P, Choy C, Miller D, Williams B J Neuropathol Exp Neurol. 2021; 80(11):1012–1023.

PMID: 34524448 PMC: 9432143. DOI: 10.1093/jnen/nlab092.


BMP antagonists in tissue development and disease.

Correns A, Zimmermann L, Baldock C, Sengle G Matrix Biol Plus. 2021; 11:100071.

PMID: 34435185 PMC: 8377005. DOI: 10.1016/j.mbplus.2021.100071.


References
1.
M Dellatore S, Garcia A, Miller W . Mimicking stem cell niches to increase stem cell expansion. Curr Opin Biotechnol. 2008; 19(5):534-40. PMC: 2585613. DOI: 10.1016/j.copbio.2008.07.010. View

2.
Chin L, Xia Y, Discher D, Janmey P . Mechanotransduction in cancer. Curr Opin Chem Eng. 2017; 11:77-84. PMC: 5362117. DOI: 10.1016/j.coche.2016.01.011. View

3.
Sung C, Li D, Andrews E, Drapkin R, Benjamin T . Promoter methylation of the SALL2 tumor suppressor gene in ovarian cancers. Mol Oncol. 2013; 7(3):419-27. PMC: 5528472. DOI: 10.1016/j.molonc.2012.11.005. View

4.
Nassar D, Blanpain C . Cancer Stem Cells: Basic Concepts and Therapeutic Implications. Annu Rev Pathol. 2016; 11:47-76. DOI: 10.1146/annurev-pathol-012615-044438. View

5.
Morfouace M, Lalier L, Bahut M, Bonnamain V, Naveilhan P, Guette C . Comparison of spheroids formed by rat glioma stem cells and neural stem cells reveals differences in glucose metabolism and promising therapeutic applications. J Biol Chem. 2012; 287(40):33664-74. PMC: 3460464. DOI: 10.1074/jbc.M111.320028. View